688426 康为世纪
交易中 07-17 11:28:27
资讯
新帖
简况
每周股票复盘：康为世纪（688426）股东大会通过超募资金补流议案
证券之星 · 07-05
每周股票复盘：康为世纪（688426）股东大会通过超募资金补流议案
每周股票复盘：康为世纪（688426）拟用4500万超募资金补流
证券之星 · 06-20
每周股票复盘：康为世纪（688426）拟用4500万超募资金补流
康为世纪（688426）披露拟使用4500万元超募资金永久补充流动资金，6月16日股价上涨0.73%
证券之星 · 06-16
康为世纪（688426）披露拟使用4500万元超募资金永久补充流动资金，6月16日股价上涨0.73%
股市必读：康为世纪（688426）今年截至6月2日累计跌幅已超25%
证券之星 · 06-03
股市必读：康为世纪（688426）今年截至6月2日累计跌幅已超25%
康为世纪(688426.SH)：艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒(酶联免疫层析法)获得医疗器械注册证
智通财经 · 05-27
康为世纪(688426.SH)：艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒(酶联免疫层析法)获得医疗器械注册证
股市必读：康为世纪（688426）今年截至5月26日累计跌幅已超20%
证券之星 · 05-27
股市必读：康为世纪（688426）今年截至5月26日累计跌幅已超20%
【私募调研记录】华夏未来调研康为世纪
证券之星 · 05-26
【私募调研记录】华夏未来调研康为世纪
康为世纪（688426）披露2025年年度股东会决议公告，5月22日股价上涨2.78%
证券之星 · 05-22
康为世纪（688426）披露2025年年度股东会决议公告，5月22日股价上涨2.78%
每周股票复盘：康为世纪（688426）2025年营收1.94亿增53.74%
证券之星 · 05-10
每周股票复盘：康为世纪（688426）2025年营收1.94亿增53.74%
康为世纪（688426）披露2025年年度股东会会议资料，5月8日股价上涨2.34%
证券之星 · 05-08
康为世纪（688426）披露2025年年度股东会会议资料，5月8日股价上涨2.34%
康为世纪（688426）披露部分董事、高管减持期满未减持结果公告，5月6日股价上涨2.11%
证券之星 · 05-06
康为世纪（688426）披露部分董事、高管减持期满未减持结果公告，5月6日股价上涨2.11%
每周股票复盘：康为世纪（688426）股东户数增14.98%，一季度收入增37.19%
证券之星 · 05-02
每周股票复盘：康为世纪（688426）股东户数增14.98%，一季度收入增37.19%
图解康为世纪一季报：第一季度单季净利润同比增长32.50%
证券之星 · 04-29
图解康为世纪一季报：第一季度单季净利润同比增长32.50%
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
证券之星 · 04-29
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元
智通财经 · 04-29
康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元
康为世纪（688426）7380万股限售股将于4月27日解禁，占总股本65.6%
证券之星 · 04-27
康为世纪（688426）7380万股限售股将于4月27日解禁，占总股本65.6%
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
证券之星 · 04-24
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
图解康为世纪年报：第四季度单季净利润同比增长49.23%
证券之星 · 04-24
图解康为世纪年报：第四季度单季净利润同比增长49.23%
每周股票复盘：康为世纪（688426）65.6%限售股将上市流通
证券之星 · 04-19
每周股票复盘：康为世纪（688426）65.6%限售股将上市流通
康为世纪（688426）披露首次公开发行部分限售股上市流通公告，4月17日股价下跌1.27%
证券之星 · 04-17
康为世纪（688426）披露首次公开发行部分限售股上市流通公告，4月17日股价下跌1.27%
公司概况
公司名称：
江苏康为世纪生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2022-10-25
主营业务：
江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂以及分子诊断试剂盒。
发行价格：
48.98
{"stockData":{"symbol":"688426","market":"SH","secType":"STK","nameCN":"康为世纪","latestPrice":16.51,"timestamp":1784258907000,"preClose":17.51,"halted":0,"volume":1032422,"delay":0,"changeRate":-0.0571,"floatShares":112000000,"shares":112000000,"eps":-0.8892,"marketStatus":"交易中","change":-1,"latestTime":"07-17 11:28:27","open":17.4,"high":17.73,"low":16.51,"amount":17535700,"amplitude":0.0697,"askPrice":16.52,"askSize":2,"bidPrice":16.5,"bidSize":13,"shortable":0,"etf":0,"ttmEps":-0.8892,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1784259000000},"marketStatusCode":2,"adr":0,"adjPreClose":17.51,"symbolType":"stock_kcb","openAndCloseTimeList":[[1784251800000,1784259000000],[1784264400000,1784271600000]],"highLimit":19.26,"lowLimit":15.76,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112493716,"isCdr":false,"pbRate":1.47,"roa":"--","roe":"--","epsLYR":-0.977,"committee":-0.196429,"marketValue":1857000000,"turnoverRate":0.0092,"status":1,"floatMarketCap":1853000000},"requestUrl":"/m/hq/s/688426/wiki","defaultTab":"wiki","newsList":[{"id":"2649924466","title":"每周股票复盘：康为世纪（688426）股东大会通过超募资金补流议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2649924466","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649924466?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:14","pubTimestamp":1783196051,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，康为世纪报收于18.34元，较上周的19.11元下跌4.03%。本周，康为世纪6月29日盘中最高价报19.46元。本周关注点公司公告汇总：股东大会审议通过使用部分超募资金永久补充流动资金的议案，同意股数占比99.9297%。公司公告汇总上海市通力律师事务所就江苏康为世纪生物科技股份有限公司2026年第二次临时股东会的召集召开程序、出席人员资格、表决程序及表决结果出具法律意见。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644206630","title":"每周股票复盘：康为世纪（688426）拟用4500万超募资金补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2644206630","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644206630?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:42","pubTimestamp":1781898134,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，康为世纪报收于16.32元，较上周的16.88元下跌3.32%。本周，康为世纪6月15日盘中最高价报17.25元。6月18日盘中最低价报15.83元，股价触及近一年最低点。康为世纪当前最新总市值18.36亿元，在医疗器械板块市值排名125/129，在两市A股市值排名5081/5206。本周关注点公司公告汇总：康为世纪拟使用超募资金4,500.00万元永久补充流动资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000002167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643759371","title":"康为世纪（688426）披露拟使用4500万元超募资金永久补充流动资金，6月16日股价上涨0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643759371","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643759371?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:49","pubTimestamp":1781606951,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，康为世纪报收于16.5元，较前一交易日上涨0.73%，最新总市值为18.56亿元。该股当日开盘16.37元，最高16.65元，最低15.9元，成交额达1627.36万元，换手率为0.89%。近日，江苏康为世纪生物科技股份有限公司披露《2026年第二次临时股东会会议资料》，公告显示公司拟使用超募资金4,500.00万元永久补充流动资金，占超募资金总额15,508.19万元的29.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600036619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640253729","title":"股市必读：康为世纪（688426）今年截至6月2日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640253729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640253729?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:18","pubTimestamp":1780431492,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，康为世纪报收于18.18元，下跌4.27%，换手率1.01%，成交量1.13万手，成交额2085.45万元。交易信息汇总股价提醒6月2日康为世纪收盘报18.18元，跌4.27%，当日成交2085.45万元。该股已连续7日下跌，当年累计跌幅27.48%。前10个交易日中，主力资金累计净流出507.18万元，股价累计下跌18.95%；融资余额累计增加70.75万元，融券余量累计增加0股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300006503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638577017","title":"康为世纪(688426.SH)：艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒(酶联免疫层析法)获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2638577017","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638577017?lang=zh_cn&edition=full","pubTime":"2026-05-27 15:59","pubTimestamp":1779868763,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪 发布公告，近日，公司全资子公司江苏健为诊断科技有限公司自主研发的艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒获得国家药品监督管理局颁发的Ⅲ类《医疗器械注册证》。健为诊断自主研发的消化道病原体检测产品“艰难梭菌谷氨酸脱氢酶抗原及毒素检测试剂盒”，采用免疫层析与酶联放大反应相结合技术，可在体外对粪便样本中的艰难梭菌谷氨酸脱氢酶及毒素A/B进行快速定性检测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","09996","BK1574","BK1100","688426","159883","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638542218","title":"股市必读：康为世纪（688426）今年截至5月26日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638542218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638542218?lang=zh_cn&edition=full","pubTime":"2026-05-27 03:08","pubTimestamp":1779822494,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，康为世纪报收于19.58元，下跌4.11%，换手率1.49%，成交量1.67万手，成交额3305.29万元。交易信息汇总股价提醒5月26日康为世纪收盘报19.58元，跌4.11%，当日成交167.43万元。该股已连续3日下跌，当年累计跌幅20.35%。前10个交易日中，主力资金累计净流出866.82万元，股价累计下跌4.7%；融资余额累计增加120.86万元，融券余量累计增加0股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700002364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638026563","title":"【私募调研记录】华夏未来调研康为世纪","url":"https://stock-news.laohu8.com/highlight/detail?id=2638026563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638026563?lang=zh_cn&edition=full","pubTime":"2026-05-26 08:04","pubTimestamp":1779753898,"startTime":"0","endTime":"0","summary":"根据市场公开信息及5月25日披露的机构调研信息，知名私募华夏未来近期对1家上市公司进行了调研，相关名单如下：1）康为世纪 调研纪要：2025年度，公司实现营业收入19,352万元，同比增加53.74%，主要系基因测序、基因合成等科技服务业务的快速增长带来营业收入增长。2025年度研发费用7,737万元，同比减少22.03%，系优化研发资源配置、调整项目节奏所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026052600004958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637049318","title":"康为世纪（688426）披露2025年年度股东会决议公告，5月22日股价上涨2.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637049318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637049318?lang=zh_cn&edition=full","pubTime":"2026-05-22 18:02","pubTimestamp":1779444155,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，康为世纪报收于20.72元，较前一交易日上涨2.78%，最新总市值为23.31亿元。公司于近日披露《2025年年度股东会决议公告》。公告显示，江苏康为世纪生物科技股份有限公司于2026年5月21日召开2025年年度股东会，会议由董事会召集，董事长王春香主持，采用现场与网络投票结合方式召开。出席会议股东共41人，代表有表决权股份76,768,215股，占公司有表决权总股本的69.8326%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200035896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634412577","title":"每周股票复盘：康为世纪（688426）2025年营收1.94亿增53.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634412577","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634412577?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:23","pubTimestamp":1778354590,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，康为世纪报收于21.85元，较上周的20.84元上涨4.85%。本周，康为世纪5月8日盘中最高价报21.98元。来自业绩披露要点：2025年公司营收1.94亿元，同比增长53.74%。因净利润为负，2025年度拟不进行利润分配。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633293434","title":"康为世纪（688426）披露2025年年度股东会会议资料，5月8日股价上涨2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633293434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633293434?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:05","pubTimestamp":1778234716,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，康为世纪报收于21.85元，较前一交易日上涨2.34%，最新总市值为24.58亿元。该股当日开盘21.16元，最高21.98元，最低21.16元，成交额达2145.76万元，换手率为0.88%。近日，康为世纪发布2025年年度股东会会议资料。因净利润为负，2025年度拟不进行利润分配。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800032689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633918106","title":"康为世纪（688426）披露部分董事、高管减持期满未减持结果公告，5月6日股价上涨2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633918106","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633918106?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:44","pubTimestamp":1778064255,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，康为世纪报收于21.28元，较前一交易日上涨2.11%，最新总市值为23.94亿元。近日，江苏康为世纪生物科技股份有限公司发布《关于部分董事、高级管理人员减持期限届满未减持股份的结果公告》。截至2026年5月5日，减持期限届满，三人均未实施减持，当前持股数量及比例与减持计划披露前一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600032564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632462587","title":"每周股票复盘：康为世纪（688426）股东户数增14.98%，一季度收入增37.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632462587","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632462587?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:42","pubTimestamp":1777675331,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，康为世纪报收于20.84元，较上周的19.47元上涨7.04%。本周，康为世纪4月30日盘中最高价报20.97元。业绩披露要点：一季度主营收入5899.73万元，同比上升37.19%。公司公告汇总：中信证券称康为世纪2025年度运作规范，未发现重大违规事项。股本股东变化股东户数变动截至2026年3月31日，康为世纪股东户数为4406.0户，较12月31日增加574.0户，增幅14.98%。户均持股数量由上期的2.94万股减少至2.55万股，户均持股市值为51.14万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631949245","title":"图解康为世纪一季报：第一季度单季净利润同比增长32.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631949245","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631949245?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:22","pubTimestamp":1777458153,"startTime":"0","endTime":"0","summary":"证券之星消息，康为世纪2026年一季报显示，一季度公司主营收入5899.73万元，同比上升37.19%；归母净利润-1535.2万元，同比上升32.5%；扣非净利润-2058.1万元，同比上升28.47%；负债率8.69%，投资收益172.56万元，财务费用54.74万元，毛利率47.18%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900058779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631596517","title":"康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631596517","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631596517?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:43","pubTimestamp":1777455834,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康为世纪披露，截至2026年3月31日公司股东户数为4406.0户，较12月31日增加574.0户，增幅为14.98%。在医疗器械行业个股中，康为世纪股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年12月31日至2026年3月31日，康为世纪区间跌幅为15.95%，在此期间股东户数增加574.0户，增幅为14.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631562464","title":"康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631562464","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631562464?lang=zh_cn&edition=full","pubTime":"2026-04-29 15:58","pubTimestamp":1777449521,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪(688426.SH)披露2026年第一季度报告，报告期公司实现营收5899.73万元，同比增长37.19%;归母净利润亏损1535万元;扣非净利润亏损2058万元。基本每股收益-0.14元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630332484","title":"康为世纪（688426）7380万股限售股将于4月27日解禁，占总股本65.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630332484","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630332484?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:02","pubTimestamp":1777248142,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，康为世纪于4月27日将有7380.0万股限售股份解禁，为公司追加承诺限售股份上市流通，占公司总股本65.6%。最近一年内，该股累计解禁43.42万股，占总股本的0.39%。本次解禁后，公司还有26.61万股限售股份，占总股本0.24%。康为世纪主营业务：分子检测底层核心技术的自主研发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629814966","title":"康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629814966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629814966?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:31","pubTimestamp":1777023087,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康为世纪披露，截至2026年3月31日公司股东户数为4406.0户，较12月31日增加574.0户，增幅为14.98%。在医疗器械行业个股中，康为世纪股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.18万户。从股价来看，2025年12月31日至2026年3月31日，康为世纪区间跌幅为15.95%，在此期间股东户数增加574.0户，增幅为14.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400052643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629545158","title":"图解康为世纪年报：第四季度单季净利润同比增长49.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629545158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629545158?lang=zh_cn&edition=full","pubTime":"2026-04-24 01:43","pubTimestamp":1776966192,"startTime":"0","endTime":"0","summary":"证券之星消息，康为世纪2025年年报显示，当年度公司主营收入1.94亿元，同比上升53.74%；归母净利润-1.07亿元，同比上升31.68%；扣非净利润-1.4亿元，同比上升22.61%；其中2025年第四季度，公司单季度主营收入5394.55万元，同比上升95.51%；单季度归母净利润-3125.01万元，同比上升49.23%；单季度扣非净利润-4582.6万元，同比上升35.43%；负债率9.25%，投资收益1376.94万元，财务费用53.13万元，毛利率45.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400004226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628775135","title":"每周股票复盘：康为世纪（688426）65.6%限售股将上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2628775135","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628775135?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:30","pubTimestamp":1776540627,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，康为世纪报收于20.14元，较上周的20.16元下跌0.1%。本周，康为世纪4月16日盘中最高价报20.58元。4月13日盘中最低价报19.82元。康为世纪当前最新总市值22.66亿元，在医疗器械板块市值排名123/129，在两市A股市值排名5043/5198。上述股份锁定期为自公司股票上市之日起42个月，原因为触发延长承诺条件。本次上市流通后，相关股东剩余限售股数量为0。保荐人中信证券对本次限售股上市流通事项无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628427294","title":"康为世纪（688426）披露首次公开发行部分限售股上市流通公告，4月17日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628427294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628427294?lang=zh_cn&edition=full","pubTime":"2026-04-17 17:39","pubTimestamp":1776418776,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，康为世纪报收于20.14元，较前一交易日下跌1.27%，最新总市值为22.66亿元。公司于2026年4月17日发布《首次公开发行部分限售股上市流通公告》。公告显示，江苏康为世纪生物科技股份有限公司首次公开发行部分限售股将于2026年4月27日上市流通，本次上市流通数量为73,800,000股，占公司总股本的65.6037%。上述股东均已履行相关股份锁定承诺，不存在资金占用情况，保荐机构对本次限售股上市流通无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700033679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784258922344,"stockEarnings":[{"period":"1week","weight":0.0472},{"period":"1month","weight":0.0612},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.3517},{"period":"1year","weight":-0.2095},{"period":"ytd","weight":-0.2652}],"compareEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.0512},{"period":"3month","weight":-0.0417},{"period":"6month","weight":-0.0535},{"period":"1year","weight":0.1081},{"period":"ytd","weight":-0.0218}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏康为世纪生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"4406人(较上一季度增加14.98%)","perCapita":"25471股","listingDate":"2022-10-25","address":"江苏省泰州市海陵区医药高新区泽兰路18号","registeredCapital":"11249万元","survey":" 江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂以及分子诊断试剂盒。","listedPrice":48.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康为世纪,688426,康为世纪股票,康为世纪股票老虎,康为世纪股票老虎国际,康为世纪行情,康为世纪股票行情,康为世纪股价,康为世纪股市,康为世纪股票价格,康为世纪股票交易,康为世纪股票购买,康为世纪股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}